International Journal of Molecular Sciences (Jul 2022)

Therapeutic Benefits of Selenium in Hematological Malignancies

  • Melanie A. Ehudin,
  • Upendarrao Golla,
  • Devnah Trivedi,
  • Shobha D. Potlakayala,
  • Sairam V. Rudrabhatla,
  • Dhimant Desai,
  • Sinisa Dovat,
  • David Claxton,
  • Arati Sharma

DOI
https://doi.org/10.3390/ijms23147972
Journal volume & issue
Vol. 23, no. 14
p. 7972

Abstract

Read online

Supplementing chemotherapy and radiotherapy with selenium has been shown to have benefits against various cancers. This approach has also been shown to alleviate the side effects associated with standard cancer therapies and improve the quality of life in patients. In addition, selenium levels in patients have been correlated with various cancers and have served as a diagnostic marker to track the efficiency of treatments or to determine whether these selenium levels cause or are a result of the disease. This concise review presents a survey of the selenium-based literature, with a focus on hematological malignancies, to demonstrate the significant impact of selenium in different cancers. The anti-cancer mechanisms and signaling pathways regulated by selenium, which impart its efficacious properties, are discussed. An outlook into the relationship between selenium and cancer is highlighted to guide future cancer therapy development.

Keywords